Video-Assisted Thoracoscopic Surgery for Several Diseases of Thoracic Surgery in 1412 Patients
Un-Chol Kwon,
Hyon-Jong Kim,
Hwan-Su Riu,
Kwang-Hak Ju,
Un Song,
Gee-Yong Ri,
Il-Su Jo
Issue:
Volume 2, Issue 2, June 2017
Pages:
24-27
Received:
24 February 2017
Accepted:
31 March 2017
Published:
15 April 2017
DOI:
10.11648/j.ajprm.20170202.12
Downloads:
Views:
Abstract: Bauckground: Video-Assisted Thoracoscopic Surgery (VATS) is applied in the almost diseases of Thoracic Surgery in the world, and became a standard approach that the patients enthusiastically hope, because VATS can reduce the invasion of operation, the duration of hospitalization and aesthetically satisfy in all patients. We retrospectively reviewed our recent experience with VATS to define its role in the context of current surgical practice. Method: Between January 1999 and December 2015, 1209 patients at Pyongyang medical college hospital, Kim Il Sung university with Hyperhidrosis, kakidrosis, Raynaud’s disease, pleurisy in 1st stage and pneumothorax were treated with the use of VATS. 203 patients with pleurisy in 2nd, 3rd stage and pneumothorax, empyema, haemothorax, lung cancer, mediastinal tumor, lung tuberculoma, lung cystoma and esophageal cancer were treated with MITS (Mini-Invasion Thoracoscopic Surgery). Result: VATS was successful in achieving satisfied effects in the patients with hyperhidrosis, empyema, pneumothorax, mediastinal tumor, lung tuberculoma, lung cystoma and esophageal cancer. In 42 patients with kakidrosis VATS failed to treat and symptom recurred. In one patient with pleurisy died postoperatively, two patient experienced empyema. Conclusions: In our experience the operation approach with the use of VATS was safe and effective in the surgical treatment of several thoracic diseases. The rate of complication is low and the level of pain is acceptable without long-term sequelae.
Abstract: Bauckground: Video-Assisted Thoracoscopic Surgery (VATS) is applied in the almost diseases of Thoracic Surgery in the world, and became a standard approach that the patients enthusiastically hope, because VATS can reduce the invasion of operation, the duration of hospitalization and aesthetically satisfy in all patients. We retrospectively reviewed...
Show More
Epidemiological Factors and Preventable Tuberculosis Transmission in a Hospital Setting in Malaysia
Thana Sehgaran Shanmugam,
Nyanamalar Sivapalan,
Nirmalatiban Parthiban,
Tha Shanmuga Sundari Thana Sehgaran,
Puvanewari Subramanian
Issue:
Volume 2, Issue 2, June 2017
Pages:
28-32
Received:
5 March 2017
Accepted:
5 April 2017
Published:
3 May 2017
DOI:
10.11648/j.ajprm.20170202.13
Downloads:
Views:
Abstract: Tuberculosis (TB) is a public health challenge in Malaysia. Delay in diagnosing and treating TB patients are associated with TB transmission. These treatment delays can be reduced by identifying and managing the contributing epidemiological factors. This study measured the magnitude of the delays in TB treatment in terms of patient delay, medical visit delay and treatment initiation delay. In addition, it aims to identify epidemiological factors contributing to these delays, the disease severity and positive sputum smear outcome. This is a cross sectional study of TB patients in a district hospital and the outcomes were computed in terms of percentage, survival curve, odds ratio and confidence interval. The patient delay, medical visit delay and initiation of treatment delay are 73%, 53% and 14% respectively. Patient delay is reduced to 50% after 28 days and is eliminated after 1120 days. Malay patients and patients without family history of TB have higher risk of experiencing all three delays. Non-Malays, males, patients with family history of TB and patients with TB contact have been related to higher risk of severe form of TB and positive smear. TB transmission can be reduced by managing the epidemiological factors identified in TB control measures.
Abstract: Tuberculosis (TB) is a public health challenge in Malaysia. Delay in diagnosing and treating TB patients are associated with TB transmission. These treatment delays can be reduced by identifying and managing the contributing epidemiological factors. This study measured the magnitude of the delays in TB treatment in terms of patient delay, medical v...
Show More
